Check out Pro
Top CompaniesRecent TradesCluster BuysSectorsBlog
Join the Insiderviz Pro waitlist
Societal CDMO, Inc. (SCTL)
Fund
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
28 Aug 2023
Cant Elena
Director
Societal CDMO, Inc.
(SCTL)
103,620+40%
30,000
$0.40
$12,000.00
BUY
28 Aug 2023
CHURCHILL WINSTON J
Director
Societal CDMO, Inc.
(SCTL)
301,602+26%
62,500
$0.40
$25,000.00
BUY
28 Aug 2023
Reasons Bryan M.
Director
Societal CDMO, Inc.
(SCTL)
291,049+27%
62,500
$0.40
$25,000.00
BUY
28 Aug 2023
Weisman Wayne
Director
Societal CDMO, Inc.
(SCTL)
308,602+25%
62,500
$0.40
$25,000.00
BUY
28 Aug 2023
Miller James Charles
Director
Societal CDMO, Inc.
(SCTL)
227,543+19%
37,500
$0.40
$15,000.00
BUY
28 Aug 2023
Ashton William
Director
Societal CDMO, Inc.
(SCTL)
263,622+9%
22,222
$0.46
$10,111.01
BUY
28 Aug 2023
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
1,098,940+12%
125,000
$0.40
$50,000.00
BUY
24 Aug 2023
AWM Investment Company, Inc.
10% Owner
Societal CDMO, Inc.
(SCTL)
10,266,144+1%
140,000
$0.40
$56,000.00
BUY
23 Aug 2023
Arens Mathew Paul
Director, 10% Owner
Societal CDMO, Inc.
(SCTL)
19,676,396+46%
6,250,000
$0.40
$2,500,000.00
SELL
27 Apr 2023
AWM Investment Company, Inc.
10% Owner
Societal CDMO, Inc.
(SCTL)
8,476,052-4%
370,000
$0.70
$259,037.00
BUY
15 Nov 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
509,468+0%
660
$1.71
$1,128.60
BUY
17 Oct 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
508,808+0%
625
$1.69
$1,056.25
BUY
15 Sep 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
508,183+0%
714
$1.41
$1,006.74
BUY
15 Aug 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
507,469+0%
757
$1.26
$953.82
BUY
15 Jul 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
506,712+0%
1,150
$0.81
$930.81
BUY
15 Jun 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
505,562+0%
1,562
$0.68
$1,062.16
BUY
16 May 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
504,000+0%
1,086
$0.96
$1,043.65
BUY
18 Apr 2022
AWM Investment Company, Inc.
10% Owner
Societal CDMO, Inc.
(SCTL)
5,109,601+0%
27,700
$1.55
$43,027.66
BUY
18 Apr 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Societal CDMO, Inc.
(SCTL)
502,914+0%
625
$1.63
$1,018.75
BUY
18 Mar 2022
Miller James Charles
Director
Societal CDMO, Inc.
(SCTL)
28,923+3%
1,000
$2.15
$2,145.00
BUY
15 Mar 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Recro Pharma, Inc.
(REPH)
524,879+0%
512
$1.96
$1,003.52
BUY
15 Feb 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Recro Pharma, Inc.
(REPH)
524,367+0%
571
$1.77
$1,010.67
BUY
18 Jan 2022
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Recro Pharma, Inc.
(REPH)
154,759+0%
602
$1.68
$1,011.36
SELL
21 Dec 2021
AWM Investment Company, Inc.
10% Owner
Recro Pharma, Inc.
(REPH)
5,081,901-1%
99,398
$1.55
$154,235.88
SELL
16 Dec 2021
AWM Investment Company, Inc.
10% Owner
Recro Pharma, Inc.
(REPH)
5,181,299-0%
50,000
$1.61
$80,500.00
BUY
15 Dec 2021
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Recro Pharma, Inc.
(REPH)
154,157+0%
617
$1.61
$993.37
SELL
13 Dec 2021
AWM Investment Company, Inc.
10% Owner
Recro Pharma, Inc.
(REPH)
5,231,299-0%
50,602
$1.62
$81,785.31
BUY
17 Nov 2021
Miller James Charles
Director
Recro Pharma, Inc.
(REPH)
27,923+3%
1,000
$1.69
$1,688.60
BUY
12 Nov 2021
Lake Ryan David
Chief Financial Officer, Officer
Recro Pharma, Inc.
(REPH)
374,335+0%
1,212
$1.65
$1,997.04
BUY
12 Nov 2021
ENLOE J DAVID JR
Chief Executive Officer, Director, Officer
Recro Pharma, Inc.
(REPH)
153,540+1%
1,725
$1.68
$2,895.24
SELL
10 Jun 2021
AWM Investment Company, Inc.
10% Owner
Recro Pharma, Inc.
(REPH)
4,685,748-9%
466,667
$2.21
$1,029,890.75
SELL
22 Dec 2020
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,097,938-2%
56,375
$3.17
$178,708.75
SELL
22 Dec 2020
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
701,017-2%
18,830
$3.17
$59,691.10
SELL
18 Dec 2020
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,154,313-0%
18,587
$3.03
$56,326.05
SELL
18 Dec 2020
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
719,847-0%
6,208
$3.03
$18,812.72
SELL
17 Apr 2020
HENWOOD GERALDINE
President and CEO, Director, Officer
Recro Pharma, Inc.
(REPH)
161,194-33%
80,000
$8.22
$657,600.00
BUY
17 May 2019
Ajdler Arnaud
Director
Recro Pharma, Inc.
(REPH)
1,104,546+4%
44,600
$8.07
$360,000.00
SELL
13 May 2019
HENWOOD GERALDINE
President and CEO, Director, Officer
Recro Pharma, Inc.
(REPH)
219,447-42%
161,458.69
$7.97
$1,287,295.50
SELL
24 May 2018
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,206,725-8%
209,620
$5.22
$1,093,182.00
SELL
13 Mar 2018
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,236,025-9%
223,000
$9.03
$2,014,000.00
SELL
9 Mar 2018
Berelowitz Michael
Director
Recro Pharma, Inc.
(REPH)
0-100%
8,362.5
$9.37
$78,346.50
SELL
4 Jan 2018
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,172,900-0%
5,276.18
$7.93
$41,822.36
SELL
4 Jan 2018
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
726,055-0%
1,760.585
$7.93
$13,955.52
SELL
2 Jan 2018
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,177,632-1%
43,273.15
$7.97
$344,687.62
SELL
2 Jan 2018
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
727,634-1%
14,454.86
$7.97
$115,138.63
SELL
28 Dec 2017
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,216,442-0%
20,327.564
$8.32
$169,080.50
SELL
28 Dec 2017
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
740,598-0%
6,790.35
$8.32
$56,480.84
SELL
26 Dec 2017
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,234,673-0%
14,705.735
$8.57
$126,055.77
SELL
26 Dec 2017
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
746,688-0%
4,911.575
$8.57
$42,101.40
SELL
20 Dec 2017
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,476,025-3%
84,740
$8.85
$750,240.00
SELL
12 Dec 2017
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,520,262-3%
103,959.26
$8.84
$919,127.60
SELL
5 Dec 2017
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,605,262-4%
111,500
$8.97
$1,000,000.00
SELL
28 Nov 2017
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,867,284-7%
248,216.84
$8.59
$2,133,062.50
SELL
21 Nov 2017
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,943,079-6%
192,011.92
$8.47
$1,626,564.80
SELL
12 Jun 2017
Flynn James E
10% Owner, Possible Member of 10% Group
Recro Pharma, Inc.
(REPH)
1,176,685-9%
123,148.41
$5.73
$706,225.75
SELL
7 Jun 2017
Flynn James E
10% Owner, Possible Member of 10% Group
Recro Pharma, Inc.
(REPH)
1,287,132-5%
70,097.82
$6.33
$444,009.62
SELL
12 May 2017
Stonepine Capital Management, LLC
10% Owner
Recro Pharma, Inc.
(REPH)
1,976,310-22%
568,650
$6.64
$3,774,204.00
SELL
9 May 2017
Stonepine Capital Management, LLC
10% Owner
Recro Pharma, Inc.
(REPH)
2,413,684-10%
272,761.34
$6.86
$1,871,765.40
SELL
3 May 2017
Stonepine Capital Management, LLC
10% Owner
Recro Pharma, Inc.
(REPH)
2,686,169-8%
242,298.42
$6.90
$1,672,961.20
SELL
14 Mar 2017
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,247,922-2%
50,149.355
$7.18
$359,992.38
SELL
14 Mar 2017
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
751,093-2%
16,750.645
$7.18
$120,242.83
SELL
17 Feb 2017
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,292,899-0%
11,131.045
$6.81
$75,790.94
SELL
17 Feb 2017
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
766,116-0%
3,717.41
$6.81
$25,311.73
SELL
14 Feb 2017
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,302,882-0%
13,452.476
$7.07
$95,171.16
SELL
14 Feb 2017
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
769,450-0%
4,493.45
$7.07
$31,789.46
SELL
13 Feb 2017
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,314,887-0%
8,849.755
$7.15
$63,261.06
SELL
13 Feb 2017
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
773,480-0%
2,955.865
$7.15
$21,129.53
BUY
16 Dec 2016
Flynn Karen
Director
Recro Pharma, Inc.
(REPH)
800+969%
892
$6.01
$5,364.00
BUY
15 Dec 2016
ALTOMARI ALFRED
Director
Recro Pharma, Inc.
(REPH)
1,500+969%
1,672.5
$5.87
$9,825.00
BUY
15 Dec 2016
Weisman Wayne
Director
Recro Pharma, Inc.
(REPH)
7,000+969%
7,805
$5.87
$45,830.00
BUY
13 Dec 2016
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
3,100,086+30%
724,750
$5.38
$3,900,000.00
BUY
16 Aug 2016
Broadfin Healthcare Master Fund Ltd
10% Owner
Recro Pharma, Inc.
(REPH)
2,450,086+21%
434,850
$6.73
$2,925,000.00
BUY
31 May 2016
Graff Fred
Chief Commercial Officer, Officer
Recro Pharma, Inc.
(REPH)
8,000+969%
8,920
$7.59
$67,707.20
BUY
26 May 2016
McCallum Stewart
Chief Medical Officer, Officer
Recro Pharma, Inc.
(REPH)
1,250+969%
1,393.75
$7.37
$10,275.00
BUY
23 May 2016
Mack Randall
Senior VP, Development, Officer
Recro Pharma, Inc.
(REPH)
2,000+969%
2,230
$5.65
$12,600.00
SELL
23 May 2016
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,322,824-0%
8,359.155
$5.65
$47,231.85
SELL
23 May 2016
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
776,131-0%
2,790.845
$5.65
$15,769.15
SELL
19 May 2016
SCP Vitalife Partners II LP
10% Owner
Recro Pharma, Inc.
(REPH)
2,330,321-0%
20,895.1
$5.79
$120,967.08
BUY
19 May 2016
Nichols Donna
CAO/Controller, Officer
Recro Pharma, Inc.
(REPH)
2,340+118%
1,271.1
$5.81
$7,387.20
SELL
19 May 2016
SCP Vitalife Partners (Israel) II, L.P.
10% Owner
Recro Pharma, Inc.
(REPH)
778,634-0%
6,979.9
$5.79
$40,408.43
Home
Top CompaniesForm ScreenerSectors
DisclaimersPrivacyTerms of Service
ContactBlogNewsletter